Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05499741 · ClinicalTrials.gov registry record · NA

Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder

A NA study of Insomnia and Tourette's Disorder, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05499741 is a NA study of Insomnia and Tourette's Disorder that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 25 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05499741, a NA study of Insomnia and Tourette's Disorder, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the present research project is to investigate the preliminary effects of four weeks of forehead temperature-regulating therapy on insomnia in adults with Tourette's disorder and co-occurring insomnia disorder. This project will also examine the effects of the device on depression, anxiety, and daytime sleepiness, and explore its effects on tic severity.

Interventions

  • DEVICE Forehead Temperature-Regulating Therapy

Study Locations (1)

California

  • Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2023-04-27
Est. Completion 2026-01
Phase NA

What the Registry Record Tells You About NCT05499741

The ClinicalTrials.gov registry entry for NCT05499741 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (85% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Forehead Temperature-Regulating Therapy is the first listed.

NCT05499741 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05499741 about?

NCT05499741 is a clinical study titled "Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder". The primary aim of the present research project is to investigate the preliminary effects of four weeks of forehead temperature-regulating therapy on insomnia in adults with Tourette's disorder and co-occurring insomnia disorder. This project will also examine the effects of the device on depression...

What is the current status of trial NCT05499741?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-04-27. Estimated completion is 2026-01.

What conditions does trial NCT05499741 study?

This clinical trial studies the following conditions: Insomnia, Tourette's Disorder.

What interventions are being tested in trial NCT05499741?

The interventions under investigation include: Forehead Temperature-Regulating Therapy (DEVICE).

Who is sponsoring clinical trial NCT05499741?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05499741 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.